Latest "Placebo Hepatitis Virus Infection" News Stories

Hepatitis C Around the World

The global burden of the hepatitis C virus (HCV) is distressing. “[A]n estimated 130–170 million persons (2%–3% of the world’s population) are living with hepatitis C virus (HCV) infection [1]. This infection, particularly in its chronic...

Virus formerly known as hepatitis G may reduce HIV mortality

NEW YORK (Reuters Health) - In patients with HIV infection, coinfection with GB virus C (GBV-C), formerly called hepatitis G virus, is linked with significantly lower mortality, a new study shows.

Primary care physicians miss hepatitis vaccine targets

Primary care physicians are failing to meet guidelines for hepatitis A virus and hepatitis B virus vaccination in patients with chronic hepatitis C infection, according to US research.

Studies advance knowledge of HIV impact on hepatitis C infection and genes that may thwart hepatitis C infection

Infectious disease experts have found that among people infected with the hepatitis C virus (HCV), co-infection with HIV, speeds damage and scarring of liver tissue by almost a decade.

Newly Discovered Gene Linked to Hepatitis C Virus Clearance, Treatment Response

Researchers have identified a genetic variant that is strongly associated with the ability to spontaneously clear infection with the hepatitis C virus (HCV) and with the response to treatment for chronic HCV infection, the leading cause of liver canc...

Hepatitis C and HIV co-infection treatment: an interview with Prof Boecher, Boehringer Ingelheim

Chronic hepatitis C infection is one of the most frequent chronic infectious diseases worldwide. The WHO estimates that 150 million people worldwide are chronically infected with the hepatitis C virus (HCV).

Team discovers new gene that affects clearance of hepatitis C virus

(Medical Xpress)—Scientists have discovered a gene that interferes with the clearance of hepatitis C virus infection. They also identified an inherited variant within this gene, Interferon Lambda 4 (IFNL4), that predicts how people respond to treat...

Hepatitis: Hepatitis E and decompensated chronic liver disease

Hepatitis E virus (HEV) infection is the most common cause of hepatitis worldwide. In the developing world, HEV infection is also a common cause of decompensation in patients with chronic liver disease and has a very high mortality. Could the same be...

Scientists discover new gene that affects clearance of hepatitis C virus

Scientists have discovered a gene that interferes with the clearance of hepatitis C virus infection. They also identified an inherited variant within this gene, Interferon Lambda 4 (IFNL4), that predicts how people respond to treatment for hepatitis...

Prevalence of acute hepatitis C virus infection is nearly 1% among newly incarcerated inmates

study published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, estimates that the prevalence of acute hepatitis C virus (HCV) infection is nearly one percent among newly incarcerated inmates w...

Hepatitis B Infection Rates in U.S. Higher Than Thought

THURSDAY, May 31 -- As many as 2.2 million people in the United States may be infected with chronic hepatitis B virus, a new study suggests. Most of those infected come from countries in Asia and Africa, where regular vaccination for the virus has......

Studies advance knowledge of HIV impact on hepatitis C infection and genes that may thwart HCV

Infectious disease experts at Johns Hopkins have found that among people infected with the hepatitis C virus (HCV), co-infection with HIV, speeds damage and scarring of liver tissue by almost a decade.

Treating hepatitis C infection in prison is good public policy, study suggests

Incarcerated patients with chronic hepatitis C virus (HCV) infection are just as likely to respond to treatment for the disease as patients in the community, according to new findings.

Inefficient Helper T Cell Response Might Explain Why Some Patients Relapse After Clearing The Infection

Helper cells traditionally thought to only assist killer white blood cells may be the frontline warriors when battling hepatitis A infection. These are the findings from a Nationwide Children's Hospital study appearing in a recent issue of the Journa...

Vitamin B12 supplements and hepatitis C treatment: an interview with Gerardo Nardone and Alba Rocco

Since its discovery in 1989, hepatitis C virus (HCV) has been recognized as a major cause of chronic liver disease worldwide. The most recent WHO estimate of the prevalence of HCV infection is 2%, representing . about 150 million people. Every year,...

EASL Calls On The United Nations To Join The Effort To Tackle Viral Hepatitis

Marking World Hepatitis Day, 28th July 2012, the European Association for the Study of the Liver (EASL) called on the different organizations which make up the United Nations systems to take action to fight against Viral Hepatitis (Hepatitis B and C...

Therapeutic Hepatitis C Virus Antibodies

Therapeutic antibodies against Hepatitis C Virus (HCV) have not been very effective in the past and there is evidence that this may result in part from interfering antibodies generated during infection that block the action of neutralizing antibodies. These neutralizing antibodies prevent HCV infection of a host cell. The subject technologies are monoclonal antibodies against HCV that can neutral...

GS-9620 therapy suppresses hepatitis B virus infection

A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.

Treating chronic hepatitis C with milk thistle extract does not appear beneficial

Use of the botanical product silymarin, an extract of milk thistle that is commonly used by some patients with chronic liver disease, did not provide greater benefit than placebo for patients with treatment-resistant chronic hepatitis C virus (HCV) i...

[Comment] Acute hepatitis C: to treat or not to treat

Individuals recently infected with the hepatitis C virus are regarded as having acute disease. When such an infection lasts more than 6 months, the disease is considered chronic. This distinction, although arbitrary, was chosen because most patients...

In Animal Model Of Hepatitis B Infection, New Drug Stimulates Immune System To Kill Infected Cells

A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells. In a study...

NIH investigators discover new gene that affects clearance of hepatitis C virus

Scientists have discovered a gene that interferes with the clearance of hepatitis C virus infection. They also identified an inherited variant within this gene, Interferon Lambda 4 (IFNL4), that predicts how people respond to treatment for hepatitis C infection. The results of this study, by investigators at the National Cancer Institute (NCI), part of the NIH, and their collaborators at NIH and o...

Treating hepatitis C infection in prison is good public policy

(Wiley) Incarcerated patients with chronic hepatitis C virus infection are just as likely to respond to treatment for the disease as patients in the community, according to findings published in the October issue of Hepatology, a peer-reviewed journa...

CORRECTION: Gay men have higher liver-related mortality from HBV than HCV

NEW YORK (Reuters Health) - In a population of men who have sex with men (MSM) -- with a high prevalence of HIV infection -- chronic hepatitis B virus (HBV) led to twice as many liver-related deaths as chronic hepatitis C virus (HCV), researc...

Interferon-Free Therapy For Hepatitis C May Become A Reality

A new exploratory agent has been tested in the treatment of the hepatitis C virus infection (HCV), allowing patients to avoid the current interferon treatment that comes with harsh side effects. A clinical trial published in the New England Journal...